About Cutanea Life Sciences
Cutanea Life Sciences is a company based in Wayne (United States) founded in 2005 was acquired by Biofrontera in March 2019. Cutanea Life Sciences has raised $900 thousand across 3 funding rounds from investors including Biofrontera. Cutanea Life Sciences operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.
- Headquarter Wayne, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$900 K (USD)
in 3 rounds
-
Latest Funding Round
$450 K (USD), Seed
Sep 01, 2011
- Investors
-
Employee Count
Not available
-
Acquired by
Biofrontera
(Mar 25, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cutanea Life Sciences
Cutanea Life Sciences has successfully raised a total of $900K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $450 thousand completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cutanea Life Sciences
Cutanea Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Biofrontera.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Solutions for dermatological therapeutics and consumer products are provided.
|
Locked | Locked | Locked |
Investor details for Cutanea Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cutanea Life Sciences
Investment portfolio details for Cutanea Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cutanea Life Sciences
Detailed financials for Cutanea Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cutanea Life Sciences Comparisons
Peer comparison for Cutanea Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cutanea Life Sciences
Cutanea Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Developer of drugs for treating dermatology diseases
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| Locked | Locked | Locked |
Microbial therapeutics for skin diseases are developed.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for dermatology disorders are developed.
|
Detailed competitors of Cutanea Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cutanea Life Sciences
Complete news archive for Cutanea Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cutanea Life Sciences
Cutanea Life Sciences was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Cutanea Life Sciences is headquartered in Wayne, United States.
Robert Bitterman is the current CEO of Cutanea Life Sciences.
Cutanea Life Sciences is a funded company, having raised a total of $900K across 3 funding rounds to date.
Cutanea Life Sciences was established in 2005 in Wayne, United States, within the biotechnology sector focused on dermatology. Therapeutics targeting skin conditions such as acne, psoriasis, rosacea, atopic dermatitis, and HPV-induced warts are developed. A soft tissue implant remains in preclinical stages. Aktipak, combining erythromycin and benzoyl peroxide in gel form, is prescribed for acne vulgaris treatment.
Cutanea Life Sciences's top competitors include LEO Pharma, Formation Bio and Arcutis.
Cutanea Life Sciences has 1 investor. Key investors include Biofrontera.